Management Standards for Hazardous Waste Pharmaceuticals, and Amendment to the P075 Listing for Nicotine -- Rule signed by EPA Acting Administrator

Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine has been signed by EPA's Acting Administrator Wheeler. 

The final rule provides tailored and streamlined standards for managing hazardous waste pharmaceuticals that reduce the cost and compliance burden for the healthcare sector, while ensuring the safe management of hazardous waste pharmaceuticals. Additionally, EPA is taking a common-sense regulatory approach to the disposal of FDA-approved over-the-counter nicotine replacement therapies (NRTs - i.e., gums, patches, lozenges), which will no longer be considered hazardous waste when discarded.

There will be two webinars to discuss the contents of the final rule. The webinars, which are free and open to the public, are scheduled for 1 pm Eastern on the following dates:

  • Wednesday, January 9
  • Wednesday, January 23rd

Both webinars will be the same, with a one-hour general presentation about the final rule, followed by a 30-minute question and answer session. See our website to register to attend one of the webinars: https://clu-in.org/conf/tio/HazWastePharmaceuticals/


Pre-publication version of the final rule
Source: U.S. EPA